Janet Hopkins
Chief Tech/Sci/R&D Officer at AURA BIOSCIENCES, INC.
Net worth: 1 M $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Elisabet de los Pinos | M | 51 | 17 years | |
Raj Bhikhu Parekh | M | 63 | 9 years | |
Antony Mattessich | M | 57 | 3 years | |
Daniel Hochstrasser | M | 64 | 2 years | |
Sapna R. Srivastava | M | 53 | 3 years | |
David Johnson | M | 59 | 3 years | |
Alex Dasalla | M | - | 2 years | |
Giovanni Mariggi | M | 39 | 5 years | |
Ana de Pro Gonzalo | F | 57 | 2 years | |
John Young | M | 60 | 1 years | |
Karan Takhar | M | 32 | 3 years | |
Ian Pitfield | M | 58 | 4 years | |
Amy Elazzouzi | F | - | - | |
Anthony Adamis | M | 65 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 3 years |
Chinmay Umesh Bhatt | M | 51 | - | |
Carrie Murray | M | - | - | |
Nadia Waheed | M | 47 | 4 years | |
Joseph Lyons | M | - | 3 years | |
Edward Lang | M | 44 | 5 years | |
Jane Hughes | M | 50 | 5 years | |
Jason Mark Brooks | M | 52 | - | |
Shreeram Aradhye | M | 62 | 2 years | |
Aharon Gal | M | 58 | 2 years | |
Julie Feder | F | 54 | 6 years | |
Mark Plavsic | M | 63 | 1 years | |
Kees Roks | M | 61 | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Tsai | M | 57 | 4 years | |
Eric Boutin | M | - | 3 years | |
Seshu Tyagarajan | M | 57 | 2 years | |
Maha Katabi | M | 50 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 1 years |
Chris Hollowood | M | 50 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 6 years |
Renée Galá | F | 52 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 2 years |
Elizabeth Theophille | F | 57 | 7 years | |
Cadmus Rich | M | 59 | 6 years | |
Dominic Schmidt | M | 42 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | 3 years |
Marie-France Tschudin | F | 53 | 1 years | |
Natacha Theytaz | M | - | 4 years | |
Paulo Carvalho | M | - | 3 years | |
Lutz Hegemann | M | 58 | - | |
Amy Wolf | F | - | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 15 | 37.50% |
Switzerland | 14 | 35.00% |
United Kingdom | 11 | 27.50% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Janet Hopkins
- Personal Network